The effect of remimazolam, a new anesthetic, on hemodynamics

The effect of remimazolam on hemodynamics during induction of general anesthesia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1011210077

Enrollment

Registered

2022-03-22

Start date

2022-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-cardiac surgery

Interventions

Induction of general anesthesia with arterial line

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients receiving non-cardiac surgery under general anesthesia with arterial line (ASA physical status I or II)

Exclusion criteria

Exclusion criteria: Severe heart valve disease, ischemic heart disease, arrhythmia, expected difficult airway, allergy against propofol or remimazolam, acute angle closure glaucoma, myasthenia gravis

Design outcomes

Primary

Measure	Time frame
dPmx	—

Secondary

Measure	Time frame
Heart rate, mean arterial pressure, stroke volume, cardiac output, caridac index, cardiac power output, cardiac power index, systemic vascular resistance, systemic vascular resistance index, stroke volume variation, pulse pressure variation, BIS	—

Contacts

Public ContactMitsutaka Edanaga

Sapporo Medical University

edanaka@sapmed.ac.jp+81-11-611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026